Aralast Kit
Product Images NDC 0944-2815

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Aralast (NDC 0944-2815). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Takeda Pharmaceuticals America, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Aralast 01

An instructional diagram showing a person holding a vial and preparing to inject a liquid with a syringe. The image depicts the process of drawing medication from the vial into the syringe, likely related to the preparation of Aralast NP Alpha-1-Proteinase Inhibitor (Human) kit.*

FDA Label Image

Aralast 02

A line graph comparing plasma alpha-1-proteinase inhibitor (alpha1-PI) concentration in mg/mL over time (days) for two groups: ARALAST NP and ARALAST, each with 25 samples. The vertical axis ranges from 0.0 to 2.0 mg/mL, and the horizontal axis shows time from pre-dose to 35 days. Data points with error bars illustrate a declining trend in alpha1-PI concentration over time for both groups.*

FDA Label Image

Aralast 03

A scatter plot with a log scale y-axis labeled ELF AAT (uM) showing individual data points connected by lines comparing Baseline BAL and Post-Treatment BAL values. The graph depicts changes in ELF AAT levels before and after treatment.*

FDA Label Image

Aralast 04

Packaging label for Aralast NP Alpha-1-Proteinase Inhibitor (Human) 0.5 gram kit. The label includes the brand and generic names, dosage form as lyophilized powder for solution, and usage note indicating intravenous use only. It also displays manufacturer information for Shire and contains detailed content, storage, and warning statements.*

FDA Label Image

Principal Display Panel (0.5 gram Vial Label)

Aralast NP 0.5 gram kit label featuring Alpha-1-Proteinase Inhibitor (Human) by Takeda Pharmaceuticals America, Inc. The lyophilized powder is solvent detergent treated and nanofiltered. Storage instructions specify temperature not exceeding 25°C (77°F). Label includes barcode, NDC 0944-2803-03, and preparation/use instructions for intravenous administration.*

FDA Label Image

Principal Display Panel (25 mL Vial Label)

Label for Sterile Water for Injection, USP, 25 mL single-dose container for reconstitution of accompanying product. The label includes usage directions, manufacturer information (Baxalta US Inc., Lexington, MA, USA), product origin (Germany), and the Shire logo. The label also displays the NDC number 52919-014-12 and barcode.*

FDA Label Image

Aralast 07

Packaging label for Aralast NP, Alpha-1-Proteinase Inhibitor (Human) kit, showing 1 gram strength. The label notes the product is solvent detergent treated and nanofiltered lyophilized powder for solution, for intravenous use only. The labeler is Shire (a subsidiary of Takeda Pharmaceuticals America, Inc.). Additional text includes content descriptions, storage instructions, and warnings related to the plasma-derived product.*

FDA Label Image

Principal Display Panel (1 gram Vial Label)

Label for Aralast NP, containing 1 gram of Alpha-1-Proteinase Inhibitor (Human). It is a lyophilized powder for solution, solvent detergent treated and nanofiltered. The label shows the NDC 0944-2804-04 and the manufacturer as Takeda Pharmaceuticals America, Inc., with packaging information including storage and administration instructions. The brand name Aralast NP and the active ingredient are prominently displayed.*

FDA Label Image

Aralast 09

Packaging label for Sterile Water for Injection, USP, 50 mL single-dose container. Label states it is for reconstitution of an accompanying product, nonpyrogenic, and manufactured for Baxalta US Inc., Lexington, MA, USA, Product of Germany. The label includes the Shire logo and NDC 52919-011-04.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.